DEEPIKA BHARGAVA: Open Payments
NPI 1841268992 · SHERMAN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,494 in 29 payments from 14 companies in 2025. Trend: 2023 $6,520 · 2024 $896 · 2025 $1,494
Food & beverage: $1,494
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 4 | $365 |
| Axsome Therapeutics, Inc. | 2 | $242 |
| Teva Pharmaceuticals USA, Inc. | 6 | $226 |
| Tris Pharma Inc | 1 | $200 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $169 |
| Alkermes, Inc. | 2 | $55 |
| Corium, LLC | 2 | $54 |
| Janssen Pharmaceuticals, Inc | 2 | $47 |
| Eisai Inc. | 1 | $32 |
| Noven Therapeutics, LLC | 1 | $24 |
Products named: COBENFY, Auvelity, AUSTEDO XR, CAPLYTA, Azstarys, UZEDY, SPRAVATO, REXULTI.
Industry payments across TX — which companies pay providers there.
